IVVD Projected Dividend Yield
Invivyd Inc ( NASDAQ : IVVD )Invivyd is a biopharmaceutical company focused on the discovery, development and commercialization of differentiated products for the prevention and/or treatment of viral infectious disease. Co. is obtaining regulatory authorization or approval for its lead product candidate, VYD222, for the prevention and/or treatment of SARS-CoV-2 (COVID-19). VYD222 is an engineered version of adintrevimab, Co.'s investigational monoclonal antibody. Co. is developing a pipeline of product candidates which could be used in prevention or treatment of serious viral diseases, starting with COVID-19 and expanding into influenza and other high-need indications. 20 YEAR PERFORMANCE RESULTS |
IVVD Dividend History Detail IVVD Dividend News IVVD Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |